Antiretroviral therapy coverage in United Arab Emirates

United Arab Emirates: Antiretroviral therapy coverage was 77.0% in 2024. ◆ Volatile

Latest (2024)
77.0%
Change on year
down 1.3%
World rank
59th
of 143 countries
All-time high
80.0%
in 2021
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage in United Arab Emirates, 2000–2024

0204060802000201220242000: 0 % of people living with HIV2001: 21 % of people living with HIV2002: 23 % of people living with HIV2003: 21 % of people living with HIV2004: 21 % of people living with HIV2005: 21 % of people living with HIV2006: 21 % of people living with HIV2007: 20 % of people living with HIV2008: 20 % of people living with HIV2009: 22 % of people living with HIV2010: 23 % of people living with HIV2011: 26 % of people living with HIV2012: 33 % of people living with HIV2013: 34 % of people living with HIV2014: 24 % of people living with HIV2015: 24 % of people living with HIV2016: 23 % of people living with HIV2017: 26 % of people living with HIV2018: 28 % of people living with HIV2019: 30 % of people living with HIV2020: 57 % of people living with HIV2021: 80 % of people living with HIV2022: 76 % of people living with HIV2023: 78 % of people living with HIV2024: 77 % of people living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.

Analysis

United Arab Emirates recorded 77.0% for antiretroviral therapy coverage in 2024.

Compared with earlier readings it is down 1.3% on the previous year and up 220.8% over ten years.

Over the whole period, antiretroviral therapy coverage in United Arab Emirates peaked at 80.0% in 2021 and was at its lowest, 0.0%, in 2000.

That places United Arab Emirates 59th out of 143 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage in United Arab Emirates, year by year

Annual values for Antiretroviral therapy coverage (% of people living with HIV) in United Arab Emirates, 2000 to 2024.
Year % of people living with HIV Change
2000 0.0%
2001 21.0%
2002 23.0% +9.5%
2003 21.0% -8.7%
2004 21.0% +0.0%
2005 21.0% +0.0%
2006 21.0% +0.0%
2007 20.0% -4.8%
2008 20.0% +0.0%
2009 22.0% +10.0%
2010 23.0% +4.5%
2011 26.0% +13.0%
2012 33.0% +26.9%
2013 34.0% +3.0%
2014 24.0% -29.4%
2015 24.0% +0.0%
2016 23.0% -4.2%
2017 26.0% +13.0%
2018 28.0% +7.7%
2019 30.0% +7.1%
2020 57.0% +90.0%
2021 80.0% +40.4%
2022 76.0% -5.0%
2023 78.0% +2.6%
2024 77.0% -1.3%

United Arab Emirates compared with similar countries

  • United Arab Emirates's 77.0% is below the median for high income countries, which is 83.0%, 93% of the median. (40 countries reporting)
  • United Arab Emirates's 77.0% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 59.5%, 1.3× the median. (20 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage in United Arab Emirates changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2020 +90.0% 30.0% 57.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 19.0% 0.0% 23.0% 10
2010s 27.1% 23.0% 34.0% 10
2020s 73.6% 57.0% 80.0% 5

Countries ranked near United Arab Emirates

  1. 57 Côte d'Ivoire 78.0% compare
  2. 57 Guatemala 78.0% compare
  3. 59 Nepal 77.0% compare
  4. 61 Canada 76.0% compare
  5. 61 El Salvador 76.0% compare
  6. 61 Mauritania 76.0% compare
  7. 61 Morocco 76.0% compare

See the full ranking of 166 places →

More health data for United Arab Emirates

All data for United Arab Emirates →

Frequently asked questions

What is antiretroviral therapy coverage in United Arab Emirates?
Antiretroviral therapy coverage in United Arab Emirates was 77.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage recorded in United Arab Emirates?
The highest recorded value was 80.0% in 2021.
What is the lowest antiretroviral therapy coverage recorded in United Arab Emirates?
The lowest recorded value was 0.0% in 2000.
How does United Arab Emirates rank for antiretroviral therapy coverage?
United Arab Emirates ranks 59th out of 143 countries with data for 2024.
Is antiretroviral therapy coverage rising or falling in United Arab Emirates?
Over the last ten years it is up 220.8%. The long-run trend across the full record is volatile.
Where does this United Arab Emirates data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage in United Arab Emirates. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 15 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/united-arab-emirates/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/united-arab-emirates/">Antiretroviral therapy coverage in United Arab Emirates</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage (% of people living with HIV)
Unit
% of people living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
166 places, 4,061 data points, 2000–2024
Last refreshed

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.